Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats

Regulatory Peptides

Volumn 120, Issue 1-3, 2004, Pages 15-22

  Mustafa, M R ^a   Dharmani, M ^a   Kunheen, N K ^a   Sim, M K ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Angiotensin III; Des aspartate angiotensin I; Mesenteric; Renal perfusion; SHR; WKY

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I [DEASPARTIC ACID]; ANGIOTENSIN III; INDOMETACIN; PROSTAGLANDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; HYPERTENSION; ISOLATED KIDNEY; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN I; ANGIOTENSIN III; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CARDIOVASCULAR AGENTS; HYPERTENSION; IMIDAZOLES; INDOMETHACIN; KIDNEY; MALE; MESENTERIC ARTERY, SUPERIOR; PROSTAGLANDINS; PYRIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 2; VASOCONSTRICTOR AGENTS;

EID: 2642559436     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.12.010     Document Type: Article

References (33)

1. Sim M.K., Yuan H.T. Effects of des-Asp-angiotensin I on the contractile action of angiotensin II and angiotensin III. Eur. J. Pharmacol. 258:1995;175-178
2. Lim B.C., Sim M.K. Actions of des-asp-angiotensin I on the aortic rings of the normo- and hypertensive rats. Clin. Exp. Hypertens. 20:1998;105-117
3. Sim M.K., Radhakrishnan R. Novel central action of des-Asp-angiotensin I. Eur. J. Pharmacol. 994:1994;R1-R3
4. Radhakrishnan R., Sim M.K. Actions of D-amino acid-substituted analogues of des-Asp-angiotensin I on the central pressor action of angiotensin III. Eur. J. Pharmacol. 294:1995;337-339
5. Castellion A.W., Fulton R.W. Preclinical pharmacology of saralasin. Kidney Int. 9:1979;S11-S19
6. Mahon J.M., Carr R.D., Nicol A.K., Henderson I.W. Angiotensin(1-7) is an antagonist at the type 1 angiotensin II receptor. J. Hypertens. 12:1994;1377-1381
7. Santos R.A.S., Campagnole-Santos M.J., Andrade S.P. Angiotensin-(1-7): an update. Regul. Pept. 91:2000;45-62
8. Sim M.K., Soh K.S. Effects of des-Asp-angiotensin I on the electrically stimulated contraction of the rabbit pulmonary artery. Eur. J. Pharmacol. 284:1995;215-219
9. Sim M.K., Chai S.K. Subtypes of losartan-sensitive angiotensin receptor in the rabbit pulmonary artery. Br. J. Pharmacol. 117:1996;1504-1506
10. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am. J. Physiol. 259:1990;F372-F382
11. Kost C.K. Jr., Jackton E.K. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension. 21:1993;420-431
12. Vyas S.J., Jackson E.K. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J. Pharmacol. Exp. Ther. 273:1995;768-777
13. McGregor D.D. The effect of symphatetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J. Physiol. 117:1965;21-39
14. Sim M.K., Qui X.S. Angiotensins in plasma of hypertensive rats and human. Regul. Pept. 111:2003;179-182
15. Healy D.P., Song L. Kidney aminopeptidase A and hypertension: part I. Spontaneously hypertensive rats. Hypertension. 33:1999;740-745
16. Reaux A., Fournie-Zaluski M.C., David C., Zini S., Roques B.P., Corvol P., et al. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12415-13420
17. Czyzewski L.B., Pettinger W.A. Failure of feedback suppression of renin release in SHR. Am. J. Physiol. 225:1974;234-238
18. Jandeleit K., Perich R., Jackson B., Johnston C.I. Mesenteric resistance and brain microvascular angiotensin-converting enzyme in the spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 19:1992;348-352
19. Morishita R., Higaki J., Nakamura Y., Aoki M., Yamada K., Moriguchi A., et al. Effect of an antihypertensive drug on brain angiotensin II level in renal and spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 22:1995;665-669
20. Tuncer M., Vanhoutte P.M. Role of prostanoids in the increase vascular responsiveness and delayed tachyphylaxis to serotonin in the kidney of spontaneously hypertensive rats. J. Hypertens. 1991;623-629
21. Vyas S.J., Mi Z., Jackson E.K. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney. J. Pharmacol. Exp. Ther. 279:1996;114-119
22. Haddad G., Garcia R. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR. J. Mol. Cell. Cardiol. 28:1996;351-361
23. 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 305:2003;581-586
24. Goldberg M.R., Joiner P.F., Hyman A.L., Kadowitz P.J. Unusual venoconstrictor effects of angiotensin II. Pro. Soc. Exp. Biol. Med. 149:1975;707-713
25. Kuttan S.C., Sim M.K. Endothelium-dependent response of the rabbit aorta to femtomolar concentrations of angiotensin II. J. Cardiovasc. Pharmacol. 17:1991;929-934
26. Badzynska B., Grzelec-Mojzesowicz M., Dobrowolski L., Sadowski J. Differential effects of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetized rats. J. Physiol. 538:2002;159-166
27. Chatziantoniou C., Arendshorst W.J. Vascular interactions of prostaglandins with thromboxane in kidney of rats developing hypertension. Am. J. Physiol. 265:1993;F250-F256
28. 2 interactions in spontaneously hypertensive rats. Hypertension. 22:1993;688-689
29. Kawasaki H., Takasaki K., Cline W.H. Jr., Su C. Effect of angiotensin III (des-Asp1-angiotensin II) on the vascular adrenergic neurotransmission spontaneously hypertensive rats. Eur. J. Pharmacol. 147:1988;125-130
30. Schlegel P.A., Monney M., Brunner H.R. Isolated perfused mesenteric arteries of hypertensive and normotensive rats; response to norepinephrine, lysine vasopressin and angiotensin II. Clin. Exp. Hypertens. A. 1985;1583-1596
31. Kost C.K. Jr., Herzer W.A., Li P., Jackson E.K. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 269:1994;82-88
32. Sim M.K., Qiu X.S. Formation of des-Asp-angiotensin I in the hypothalamic extract of normo- and hypertensive rats. Blood Press. 3:1994;260-264
33. Sim M.K., Lim B.C. Determination of aminopeptidase X activity in tissues of normo- and hypertensive rats by capillary electrophoresis. J. Chromatogr. B. 697:1997;259-262